Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Myeloid 3Other hematologic neoplasm 2Classical hematology 2Plasma cell 1Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 11Anemia, Refractory, with Excess of Blasts 11Myelodysplastic Syndromes 8Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Venous Thromboembolism 5Anemia, Aplastic 5Myeloproliferative Disorders 4Lymphoma, Non-Hodgkin 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Lymphocytic, Chronic, B-Cell 4Fanconi Anemia 4Anemia 4Pulmonary Embolism 3Primary Myelofibrosis 3Myelodysplastic-Myeloproliferative Diseases 3Multiple Myeloma 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Hodgkin Disease 3Hematologic Neoplasms 3Congenital Bone Marrow Failure Syndromes 3Burkitt Lymphoma 3Blast Crisis 3Anemia, Sickle Cell 3Venous Thrombosis 2Recurrence 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hematologic Diseases × Classical hematology × 30 days × Clear all
NCT00001620 2026-05-29

Screening for Hematology Branch Protocols

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
10,000 enrolled
Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Disease, Hematologic Diseases, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT07379125 2026-05-22

Therapeutic RSK1 Targeting in Myelofibrosis

Washington University School of Medicine

Phase 1 Recruiting
18 enrolled
Classical hematologyMyeloid

Anemia, Bone Marrow Diseases, Hematologic Diseases, Myeloproliferative Disorders, Splenomegaly, Bone Marrow Neoplasms, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡